SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (1108)1/14/1999 10:52:00 AM
From: Henry Volquardsen   of 1115
 
YAKATAN GERALD J,C.E.O.,BUYS 17,500 ON 12/30/98 OF AVANIR PHARMA
1/14/99 7:41

FORM 4

SEC - ON 12/30/98, YAKATAN GERALD J, CHIEF EXECUTIVE OFFICER OF
AVANIR PHARMACEUTICALS (TICKER:AVNR) BOUGHT 17,500 SHARES AT
$0.56, BRINGING HOLDINGS TO 37,500 SHARES.

The Washington Service reports only purchases and sales (both
open market and private) of common stock. Further information
on our services may be obtained by calling (202) 778-1380, or
by typing WSA <GO>.

(9011303C)
-0- (WSA) Jan/14/ 99 7:40
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News